Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Fibrocyte accumulation in the lungs of cystic fibrosis patients.
Kasam RK, Gajjala PR, Jegga AG, Courtney JA, Randell SH, Kramer EL, Clancy JP, Madala SK. Kasam RK, et al. Among authors: gajjala pr. J Cyst Fibros. 2020 Sep;19(5):815-822. doi: 10.1016/j.jcf.2020.06.011. Epub 2020 Jun 25. J Cyst Fibros. 2020. PMID: 32593509 Free PMC article.
New therapeutics based on emerging concepts in pulmonary fibrosis.
Sontake V, Gajjala PR, Kasam RK, Madala SK. Sontake V, et al. Among authors: gajjala pr. Expert Opin Ther Targets. 2019 Jan;23(1):69-81. doi: 10.1080/14728222.2019.1552262. Epub 2018 Nov 28. Expert Opin Ther Targets. 2019. PMID: 30468628 Free PMC article. Review.
Notch3: A New Culprit in Fibrotic Lung Disease.
Gajjala PR, Madala SK. Gajjala PR, et al. Am J Respir Cell Mol Biol. 2021 Apr;64(4):403-404. doi: 10.1165/rcmb.2021-0024ED. Am J Respir Cell Mol Biol. 2021. PMID: 33591242 Free PMC article. No abstract available.
Discovery of the first selective and potent PROTAC degrader for the pseudokinase TRIB2.
Wen C, Gajjala PR, Liu Y, Chen B, Bal MS, Sutaria P, Yuanyuan Q, Zheng Y, Zhou Y, Zhang J, Huang W, Ren X, Wang Z, Ding K, Chinnaiyan AM, Zhou F. Wen C, et al. Among authors: gajjala pr. Eur J Med Chem. 2025 Jan 5;281:117016. doi: 10.1016/j.ejmech.2024.117016. Epub 2024 Nov 1. Eur J Med Chem. 2025. PMID: 39520729
NSD2 is a requisite subunit of the AR/FOXA1 neo-enhanceosome in promoting prostate tumorigenesis.
Parolia A, Eyunni S, Verma BK, Young E, Liu Y, Liu L, George J, Aras S, Das CK, Mannan R, Ur Rasool R, Mitchell-Velasquez E, Mahapatra S, Luo J, Carson SE, Xiao L, Gajjala PR, Venkatesh S, Jaber M, Wang X, He T, Qiao Y, Pang M, Zhang Y, Tien JC, Louw M, Alhusayan M, Cao X, Su F, Tavana O, Hou C, Wang Z, Ding K, Chinnaiyan AM, Asangani IA. Parolia A, et al. Among authors: gajjala pr. Nat Genet. 2024 Oct;56(10):2132-2143. doi: 10.1038/s41588-024-01893-6. Epub 2024 Sep 9. Nat Genet. 2024. PMID: 39251788 Free PMC article.
NSD2 is a requisite subunit of the AR/FOXA1 neo-enhanceosome in promoting prostate tumorigenesis.
Parolia A, Eyunni S, Verma BK, Young E, Liu L, George J, Aras S, Das CK, Mannan R, Rasool RU, Luo J, Carson SE, Mitchell-Velasquez E, Liu Y, Xiao L, Gajjala PR, Jaber M, Wang X, He T, Qiao Y, Pang M, Zhang Y, Alhusayan M, Cao X, Tavana O, Hou C, Wang Z, Ding K, Chinnaiyan AM, Asangani IA. Parolia A, et al. Among authors: gajjala pr. bioRxiv [Preprint]. 2024 Mar 29:2024.02.22.581560. doi: 10.1101/2024.02.22.581560. bioRxiv. 2024. Update in: Nat Genet. 2024 Oct;56(10):2132-2143. doi: 10.1038/s41588-024-01893-6 PMID: 38464251 Free PMC article. Updated. Preprint.
16 results